Susanna M. Nazarian, PhD,MD

Jefferson Health Provider

Jefferson Medical Group Jefferson Medical Group

Patient Rating

4.8/5 stars

Practice Information

Sidney Kimmel Cancer Center - Washington Township
900 Medical Center Drive
Sewell, NJ 08080-2358
Get Driving Directions
Fax:(856) 218-5327
Specialty:Breast Surgery
Focus Area:
Comprehensive Breast Center
Female to Male Top Surgery

Online Appointment Scheduling

Select an appointment type to schedule directly.

Additional Locations

Cherry Hill MOB - General Surgery & Specialty Care
2211 Chapel Avenue West
Suite 301
Cherry Hill, NJ 08002
Get Driving Directions
Fax:(856) 488-6769

Background & Education

Job Title:Associate Professor
Medical School:Johns Hopkins University School of Medicine
Internship:Johns Hopkins Hospital
Residency:Johns Hopkins Hospital
Fellowship:Hospital of the University of Pennsylvania, Johns Hopkins Hospital
Board Certification:Surgery, Surgery, General


Physician Fact Sheet 



Dr. Nazarian is a graduate of the Johns Hopkins University School of Medicine. During her training in General Surgery there, she earned her PhD from the Bloomberg School of Public Health in the Graduate Training Program in Clinical Investigation. She is board certified in General Surgery and certified in Breast Surgery by the Society of Surgical Oncology. Dr. Nazarian is also certified in abdominal transplantation by the American Society of Transplant Surgeons - her first career. Dr. Nazarian is a member of the Association for Academic Surgery, the American Society of Breast Surgeons, and serves on the Council of the Metropolitan Philadelphia Chapter of the American College of Surgeons.  

Years in Practice:


Hospital Affiliation: 

Thomas Jefferson University Hospital



Areas of Interest: 

  • Abnormal mammogram
  • Breast cancer risk assessment counseling & monitoring
  • Breast conservation surgery
  • Cancer care during pregnancy
  • Clinical trials/Investigation of clinically-driven research questions
  • Dense breasts
  • Genetic and familial predisposition to breast cancer/high risk patients
  • Gynecomastia/Male breast cancer patients
  • High risk breast lesions
  • Inflammatory breast cancer
  • Lymph node surgery/Sentinel lymph node biopsy
  • Lymphedema
  • Nipple sparing mastectomy
  • Oncoplastic surgery
  • SAVI-localized surgery
  • Skin sparing mastectomy
  • Young women with breast cancer
  • LGBTQ+ care


Kidney transplantation and donation in the transgender population: A single-institution case series

Is there an association between body mass index and 21-gene recurrence score?

Impact of 21-Gene Expression Assay on Clinical Outcomes in Node-Negative ≤ T1b Breast Cancer

Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience

An Advanced Practice Practitioner–Based Program to Reduce 30- and 90-Day Readmissions After Liver Transplantation

Inpatient pain medication administration: understanding the process and its delays

Twelve-month outcomes after transplant of hepatitis C–infected kidneys into uninfected recipients a single-group trial

Invited Letter Re: The kidney allocation system and its implications for pediatric recipients

Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients

The kidney allocation system does not appropriately stratify risk of pediatric donor kidneys: Implications for pediatric recipients

Pregnancy-induced sensitization promotes sex disparity in living donor kidney transplantation

Comparing outcomes between antibody induction therapies in kidney transplantation

Trial of transplantation of HCV-infected kidneys into uninfected recipients

Insights from a ten-year, prospective study of live kidney donors

Risk factors for nonplatelet thromboxane generation after coronary artery bypass graft surgery

Surgical management of early and late ureteral complications after renal transplantation: Techniques and outcomes

Optimal immunosuppression for HIV-positive kidney transplants: Long-term randomized controlled trials needed

Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants

Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation

Patient Ratings

Explanations the care provider gave you about your problem or condition :
Concern the care provider showed for your questions or worries :
Care provider's efforts to include you in decisions about your care :
Likelihood of your recommending this care provider to others :
Overall Rating :
Learn more about Patient Ratings